Local therapy of rectal carcinoids: A matter of debate

Archives of Surgery

Volumn 144, Issue 2, 2009, Pages 195-196

  Scherübl, Hans ^a  

^a Klinikum Am Urban   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INVASION; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARCINOID; DISEASE SEVERITY; ENDOSCOPIC ECHOGRAPHY; HUMAN; LETTER; LOCAL THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECTUM CARCINOID; RECTUM TUMOR; TUMOR VOLUME;

CARCINOID TUMOR; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; RECTAL NEOPLASMS;

EID: 61549101842     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2008.542     Document Type: Letter

References (19)

1. Kwaan MR, Goldberg J, Bleday R. Rectal carcinoid tumors: review of results after endoscopic and surgical therapy. Arch Surg. 2008;143(5):471-475.
2. Ramage JK, Goretzki P, Manfredi R, et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinology. 2008;87(1):31-39.
3. Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer. 2005;103(8):1587-1595.
4. Modlin IM, Öberg K, Chung D, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61-72.
5. Modlin I, Drozdov I, Gustafsson B, et al. Rectal neuroendocrine tumors: diagnosis and treatment. In: ModlinI, ObergK, eds. A Century of Advances in Neuroendocrine Tumor Biology and Treatment. Hanover, Germany: Felsen-stein CCCP; 2007:124-133.
6. Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T, Nagawa H; Japanese Society for Cancer of the Colon and Rectum. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007;56(6):863-868.
7. Konishi T, Watanabe T, Kishimoto J, et al. Prognosis and metastatic potential of colorectal carcinoids compared with adenocarcinomas: results of a nationwide registry over 15 years [ASCO Abstract 4054]. J Clin Oncol. 2008;26(15S)(suppl).
8. Konishi T, Watanabe T, Muto T, Kotake K, Nagawa H. Risk factors for lymph node and distant metastasis in colorectal carcinoids: an analysis of nationwide registry in Japan over 15 years [ ASCO Abstract 3620]. JClin Oncol. 2006;24(18S)(suppl).
9. Tsukamoto S, Fujita S, Yamaguchi T, et al. Clinicopathological characteristics and prognosis of rectal carcinoids. Int J Colorectal Dis. (11).
10. Kaminski M, Polkowski M, Regula J, et al. Prevalence and endoscopic features of rectal neuroendocrine tumors (carcinoids) among 50148 participants of the Polish colorectal-cancer screening programme. Gut. 2007;56(suppl III):A310.
11. Modlin IM, Lye K, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934-959.
12. Sauven P, RidgeJ, Quan S, Sigurdson ER. Anorectal carcinoid tumors: is aggressive surgery warranted? Ann Surg. 1990;211(1):67-71.
13. Shinohara T, Hotta T, Oyama T. Rectal carcinoid tumor, 6 mm in diameter, with lymph node metastases [published online ahead of print February 27, 2008]. Endoscopy. 2008;40(suppl 2):E40-E41.
14. Shim KN, Yang S, Myung S, et al. Atypical endoscopic features of rectal carcinoids. Endoscopy. 2004;36(4):313-316.
15. Scherubl H. Options for gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(3):203.
16. Matsui K, Iwase T, Kitagawa M. Small, polypoid-appearing carcinoid tumors of the rectum: clinicopathologic study of 16 cases and effectiveness of endoscopic treatment. Am J Gastroenterol. 1993;88(11):1949-1953.
17. Sakata H, Iwakiri R, Ootani A, et al. Apilot randomised controlled study to evaluate endoscopic resection using a ligation device for rectal carcinoid tumors. World J Gastroenterol. 2006;12(25):4026-4028.
18. Onozato Y, Kakizaki S, Ishihara H, et al. Endoscopic submucosal dissection forrectaltumors[publishedonlineaheadofprintMarch13, 2007]. Endoscopy. 2007;39(5):423-427.
19. Höpfner M, Schuppan D, Scherübl H. Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives. World J Gastroenterol. 2008;14(16):2461-2473.